Category Archives: Europe

Viehbacher Exits Sanofi

Christopher A. Viehbacher resigned as director of Sanofi immediately after its Board of Directors unanimously agreed to remove him as the company’s CEO yesterday. Chairman Serge Weinberg will replace Viehbacher on an interim basis.
Also posted in Global, leadership, Strategy | Tagged , | Leave a comment

NHL Treatment Market Boom Will Be Hindered in EU

The global non-hodgkin lymphoma (NHL) treatment market will increase in value from $5.6 billion in 2013 to $9.2 billion by 2020, according to GBI Research.
Also posted in R&D, Strategy | Tagged , , , , , , | Leave a comment

New Scottish Medicines Fund Boosted by UK PPRS

 The 2014 Pharmaceutical Price Regulation Scheme (PPRS), the voluntary agreement to cover pricing of branded medicines supplied to the NHS in the UK, included provisions for member companies to pay back to the Department of Health (DH) if spend went over pre-agreed growth rates.  That has translated into £150 million already for the first two […]
Posted in Europe | Tagged , , , , | Leave a comment

Pharma Feels Impact of US Tax Inversion Legislation

The recent termination of AbbVie’s deal to acquire Shire has “jolted the industry out of its reverie” by becoming pharma’s first major casualty of new US tax inversion legislation,  says research and consulting firm GlobalData.
Also posted in Deals, Global, Strategy | Tagged , , , | Leave a comment
  • Categories

  • Meta